Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Equity (2018 - 2025)

Dna X filings provide 8 years of Return on Equity readings, the most recent being 0.02% for Q4 2025.

  • On a quarterly basis, Return on Equity rose 3.0% to 0.02% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.02%, a 3.0% increase, with the full-year FY2025 number at 0.02%, up 6.0% from a year prior.
  • Return on Equity hit 0.02% in Q4 2025 for Dna X, down from 0.03% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.03% in Q3 2025 to a low of 0.04% in Q2 2022.
  • Median Return on Equity over the past 5 years was 0.0% (2024), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Equity: decreased -2bps in 2021 and later grew 4bps in 2023.
  • Dna X's Return on Equity stood at 0.02% in 2021, then skyrocketed by 100bps to 0.0% in 2022, then soared by 89bps to 0.0% in 2023, then tumbled by -60956bps to 0.01% in 2024, then skyrocketed by 398bps to 0.02% in 2025.
  • The last three reported values for Return on Equity were 0.02% (Q4 2025), 0.03% (Q3 2025), and 0.01% (Q2 2025) per Business Quant data.